Citadel Advisors - BIOANALYTICAL SYS INC ownership

BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 15 filers reported holding BIOANALYTICAL SYS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BIOANALYTICAL SYS INC
ValueSharesWeighting
Q2 2018$42,000
-19.2%
25,468
+21.9%
0.00%
Q4 2017$52,000
+92.6%
20,886
+33.9%
0.00%
Q3 2017$27,000
+8.0%
15,599
+4.4%
0.00%
Q2 2017$25,000
-28.6%
14,935
-41.5%
0.00%
Q1 2017$35,000
+218.2%
25,535
+70.4%
0.00%
Q4 2016$11,000
-42.1%
14,983
-8.9%
0.00%
Q3 2016$19,000
+26.7%
16,453
+29.2%
0.00%
Q2 2016$15,000
-53.1%
12,739
-13.9%
0.00%
Q4 2014$32,000
+18.5%
14,793
+37.8%
0.00%
Q1 2014$27,00010,7330.00%
Other shareholders
BIOANALYTICAL SYS INC shareholders Q1 2017
NameSharesValueWeighting ↓
HealthInvest Partners AB 320,234$650,0000.45%
Kessler Investment Group, LLC 42,841$87,0000.15%
NORTH STAR ASSET MANAGEMENT INC 20,000$41,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 3$00.00%
UBS Group AG 5,118$10,0000.00%
DIMENSIONAL FUND ADVISORS LP 54,038$110,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 100$203,0000.00%
STATE STREET CORP 10,200$20,0000.00%
MORGAN STANLEY 14$00.00%
BANK OF MONTREAL /CAN/ 230$00.00%
View complete list of BIOANALYTICAL SYS INC shareholders